Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
M
|
Milestone Scientific Inc
AMEX:MLSS
|
US |
Intrinsic Value
The intrinsic value for
Atea Pharmaceuticals Inc (AVIR) under the Base Case is 1.08 USD.
Compared with the current market price of 4.87 USD, the stock appears
Overvalued by 78% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Atea Pharmaceuticals Inc.
The intrinsic value for
Atea Pharmaceuticals Inc (AVIR) under the Base Case is 1.08 USD.
Compared with the current market price of 4.87 USD, the stock appears Overvalued by 78% .